Evidence indicates that pharmacotherapy is the mainstay of treatment, both in early and chronic psychosis. Despite clinical improvement, many people with psychosis develop disabilities related to domains of negative, physical health and mood symptoms, cognitive dysfunction, and socioeconomic disadvantages, through all stages of psychoses. This implies a key need for psychosocial interventions.
Initiation of combined drug and psychosocial treatments plays a significant part in the early phase of psychosis. Several meta-analyses have highlighted the need to address the complex health, social, and economic needs of those diagnosed with a chronic and highly disabling illness such as schizophrenia . A recent systematic review of recovery-oriented interventions delivered in pro-recovery and non-stigmatizing contexts has been reported to share several critical mechanisms, that propel service…
